Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
Abstract
Mucosal healing (MH) is now considered as a major treatment goal in clinical trials and clinical practice for patients with inflammatory bowel disease (IBD). MH is associated with sustained clinical remission, steroid-free remission, and reduced rates of hospitalization and surgery. There is a well- …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
Remission Induction
Colitis
Ulcerative / drug therapy*
Gastrointestinal Agents / therapeutic use*
time factors
anti-inflammatory agents / therapeutic use*
crohn disease / drug therapy*
intestinal mucosa / pathology
ulcerative / pathology
intestinal mucosa / physiopathology
wound healing / drug effects*
colon / pathology
intestinal mucosa / drug effects*
laurent peyrin-biroulet
colonoscopy
pmid:27043489
doi:10.1586/17474124.2016.1174064
guillaume pineton de chambrun
pierre blanc
ulcerative / physiopathology
colon / drug effects*
colon / physiopathology
crohn disease / pathology
crohn disease / physiopathology
Access
Citation
ID:
267331
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
267331
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet